Jazz Pharmaceuticals plc
Symbole: JAZZ
NASDAQ
124.79
USDPrix du marché aujourd'hui
16.5122
Ratio P/E
0.0368
Ratio PEG
7.78B
Cap MRK
- 0.00%
Rendement DIV
Jazz Pharmaceuticals plc (JAZZ) États financiers
Bilan
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5742.22 | 1626.3 | 881.5 | 591.4 | |||||||||||||||||||
balance-sheet.row.short-term-investments | 930 | 420 | 30 | 0 | |||||||||||||||||||
balance-sheet.row.net-receivables | 2567.96 | 705.8 | 651.5 | 563.4 | |||||||||||||||||||
balance-sheet.row.inventory | 2540.86 | 597 | 714.1 | 1072.7 | |||||||||||||||||||
balance-sheet.row.other-current-assets | 754.22 | 334.8 | 267.2 | 252.4 | |||||||||||||||||||
balance-sheet.row.total-current-assets | 12304.18 | 3263.9 | 2606.1 | 2611.3 | |||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 1123.89 | 235 | 301.4 | 343.4 | |||||||||||||||||||
balance-sheet.row.goodwill | 6924.57 | 1753.1 | 1692.7 | 1827.6 | |||||||||||||||||||
balance-sheet.row.intangible-assets | 22305.88 | 5418 | 5794.4 | 7152.3 | |||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 29230.45 | 7171.2 | 7487.1 | 8979.9 | |||||||||||||||||||
balance-sheet.row.long-term-investments | 25.24 | 4.7 | 5.5 | 12 | |||||||||||||||||||
balance-sheet.row.tax-assets | 1771.38 | 477.8 | 376.2 | 311.1 | |||||||||||||||||||
balance-sheet.row.other-non-current-assets | 449.94 | 240.7 | 58.9 | 40.8 | |||||||||||||||||||
balance-sheet.row.total-non-current-assets | 32600.91 | 8129.4 | 8229.1 | 9687.3 | |||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-assets | 44905.09 | 11393.4 | 10835.3 | 12298.6 | |||||||||||||||||||
balance-sheet.row.account-payables | 436.48 | 102.8 | 90.8 | 100.3 | |||||||||||||||||||
balance-sheet.row.short-term-debt | 1324.61 | 624.4 | 31 | 31 | |||||||||||||||||||
balance-sheet.row.tax-payables | 231.72 | 35.1 | 7.7 | 9.6 | |||||||||||||||||||
balance-sheet.row.long-term-debt-total | 21794.59 | 5108 | 5765.2 | 6106.1 | |||||||||||||||||||
Deferred Revenue Non Current | 64.26 | 64.3 | 0 | 0.5 | |||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 3531.91 | - | - | - | |||||||||||||||||||
balance-sheet.row.other-current-liab | 3168.01 | 774.5 | 811 | 675.9 | |||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 25853.81 | 6119.7 | 6816.3 | 7524.1 | |||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 297.5 | 64.3 | 71.8 | 87.2 | |||||||||||||||||||
balance-sheet.row.total-liab | 30818 | 7656.4 | 7749.5 | 8333.4 | |||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.common-stock | 0.24 | 0.1 | 0.1 | 0.1 | |||||||||||||||||||
balance-sheet.row.retained-earnings | 3377.81 | 878.7 | 733.6 | 830.2 | |||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -3724.13 | -841.7 | -1125.5 | -400.4 | |||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 14433.16 | 3700 | 3477.6 | 3535.3 | |||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 14087.09 | 3737 | 3085.7 | 3965.2 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 44905.09 | 11393.4 | 10835.3 | 12298.6 | |||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||||
balance-sheet.row.total-equity | 14087.09 | 3737 | 3085.7 | 3965.2 | |||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 44905.09 | - | - | - | |||||||||||||||||||
Total Investments | 940.2 | 424.7 | 35.5 | 12 | |||||||||||||||||||
balance-sheet.row.total-debt | 23183.46 | 5796.7 | 5796.2 | 6137.1 | |||||||||||||||||||
balance-sheet.row.net-debt | 18191.25 | 4590.3 | 4914.7 | 5545.7 |
Tableau des flux de trésorerie
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 414.83 | 414.8 | -224.1 | -329.7 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 638.7 | 638.7 | 629.5 | 552.5 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -260.22 | -260.2 | -292.3 | 69.2 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 226.84 | 226.8 | 222 | 189 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -204.44 | -204.4 | 9.9 | -48 | |||||||||||||||||||
cash-flows.row.account-receivables | -51.88 | -51.9 | -90.1 | -92.7 | |||||||||||||||||||
cash-flows.row.inventory | -13.42 | -13.4 | -49.6 | -48.9 | |||||||||||||||||||
cash-flows.row.account-payables | 9.6 | 9.6 | -11.2 | 57 | |||||||||||||||||||
cash-flows.row.other-working-capital | -148.74 | -148.7 | 160.9 | 36.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 276.29 | 276.3 | 926.9 | 345.4 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 1092.01 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -24.96 | -24 | -498.2 | -45.5 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -20 | 0 | 53 | -6234.8 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -390.1 | -390.1 | -61 | -26.8 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 270 | 270 | 60 | 1095 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 2 | -19 | 0 | 0 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -163.06 | -163.1 | -446.2 | -5212.1 | |||||||||||||||||||
cash-flows.row.debt-repayment | -31 | -31 | -582 | -1320.6 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 46.46 | 46.5 | 98 | 135.3 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -313.03 | -269.8 | -0.1 | -35.6 | |||||||||||||||||||
cash-flows.row.dividends-paid | -112.28 | 0 | -98 | -99.7 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 104.59 | -51 | 52.6 | 5291.1 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -305.25 | -305.3 | -529.5 | 3970.5 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1.14 | 1.1 | -6.2 | -3.2 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 634.83 | 354.8 | 290 | -466.3 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4992.22 | 1206.3 | 881.5 | 591.4 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4357.39 | 851.5 | 591.4 | 1057.8 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 1092.01 | 1092 | 1272 | 778.5 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -24.96 | -24 | -498.2 | -45.5 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 1067.05 | 1068 | 773.8 | 733 |
Row du compte de résultat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 3834.2 | 3834.2 | 3659.4 | 3094.2 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 587.13 | 1043.9 | 540.5 | 440.8 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 3247.07 | 2790.3 | 3118.9 | 2653.5 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 849.66 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 1286.53 | 1476.9 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 2587.77 | 2131.1 | 2606.6 | 2483.2 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 3174.9 | 3174.9 | 3147.1 | 2924 | ||||||||||||||||||||
income-statement-row.row.interest-income | 65.2 | 65.1 | 11.5 | 1.8 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 308.77 | 351.1 | 288.2 | 278.8 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -215.41 | -361.4 | -885.1 | -283.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 1286.53 | 1476.9 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -215.41 | -361.4 | -885.1 | -283.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 308.77 | 351.1 | 288.2 | 278.8 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 632.12 | 638.7 | 599.2 | 525.8 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1290.43 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 658.31 | 659.3 | 512.3 | 170.3 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 297.93 | 297.9 | -372.8 | -112.8 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | -119.91 | -119.9 | -158.6 | 216.1 | ||||||||||||||||||||
income-statement-row.row.net-income | 414.83 | 414.8 | -214.1 | -329 |
Questions fréquemment posées
Quel est le total de Jazz Pharmaceuticals plc (JAZZ) de l'actif total?
Jazz Pharmaceuticals plc (JAZZ) Le total des actifs est 11393359000.000.
Quel est le revenu annuel de l'entreprise?
Le revenu annuel est 1984075000.000.
Quelle est la marge bénéficiaire de l'entreprise?
La marge bénéficiaire de l'entreprise est 0.847.
Quel est le flux de trésorerie disponible de l'entreprise?
Le flux de trésorerie disponible est 17.051.
Quelle est la marge bénéficiaire nette de l'entreprise?
La marge bénéficiaire nette est 0.108.
Quel est le revenu total de l'entreprise?
Le revenu total est 0.172.
Qu'est-ce que Jazz Pharmaceuticals plc (JAZZ) bénéfice net (revenu net)?
Le bénéfice net (revenu net) est 414832000.000.
Quel est l'endettement total de l'entreprise?
La dette totale est 5796653000.000.
Quel est le montant des dépenses d'exploitation?
Les dépenses d'exploitation sont 2131063000.000.
Quel est le montant de la trésorerie de l'entreprise?
Les liquidités de l'entreprise sont 1206310000.000.